Comparison of Insulin Glargine and Detemir on Hormone Factors Affecting Appetite in Patients with Type 1 Diabetes

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191208045651N1

Enrollment

Registered

2019-12-23

Start date

2019-04-30

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes. Type 1 Diabetes mellitus

Interventions

Intervention 1: Intervention group 1: Includes new cases of type 1 diabetes that hospitalized. In this group, samples (n=21) received insulin Glargine for 3 months. Insulin Glargine was given to the p

Eligibility

Sex/Gender

All

Age

1 Years to 18 Years

Inclusion criteria

Inclusion criteria: Parent's Consent new cases of children with type1 diabetes Children under 18 years old.

Exclusion criteria

Exclusion criteria: No Parental consent Non-cooperation until the end of the study (Discontinuation of use)

Design outcomes

Primary

Measure	Time frame
Increase or decrease in Leptin hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).;Increase or decrease in Gherlin hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).;Increase or decrease in AGRP hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).;Increase or decrease in PYY 3-36 hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).	—

Measure

Time frame

Increase or decrease in Leptin hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).;Increase or decrease in Gherlin hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).;Increase or decrease in AGRP hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).;Increase or decrease in PYY 3-36 hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHosein Momeni

Iran University of Medical Sciences

momeni.h@iums.ac.ir+98 21 2304 6252

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026